Okada CY - Search Results

1

Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab.

Gay ND, Okada CY, Chen AI, Scott EC. Gay ND, et al. Among authors: okada cy. Ther Adv Hematol. 2017 May;8(5):175-180. doi: 10.1177/2040620717695723. Epub 2017 Mar 28. Ther Adv Hematol. 2017. PMID: 28473905 Free PMC article. Review.

2

Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors.

Smith SD, Chen A, Spurgeon S, Okada C, Fan G, Dunlap J, Braziel R, Maziarz R. Smith SD, et al. Ther Adv Hematol. 2013 Dec;4(6):349-53. doi: 10.1177/2040620713505048. Ther Adv Hematol. 2013. PMID: 24319570 Free PMC article.

3

Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.

Chen AI, Leonard JT, Okada CY, Gay ND, Chansky K, Fan G, Dunlap JB, Raess PW, Braziel RM, Stentz A, Maziarz RT. Chen AI, et al. Among authors: okada cy. Leuk Lymphoma. 2018 Aug;59(8):1884-1889. doi: 10.1080/10428194.2017.1406085. Epub 2017 Dec 3. Leuk Lymphoma. 2018. PMID: 29199519

4

Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia.

Gay ND, Kozin E, Okada C, Danilov AV, Spurgeon S. Gay ND, et al. Leuk Lymphoma. 2018 Sep;59(9):2258-2260. doi: 10.1080/10428194.2017.1410890. Epub 2017 Dec 18. Leuk Lymphoma. 2018. PMID: 29249186 No abstract available.

5

Colorectal Lymphoma: A Review.

Gay ND, Chen A, Okada CY. Gay ND, et al. Among authors: okada cy. Clin Colon Rectal Surg. 2018 Sep;31(5):309-316. doi: 10.1055/s-0038-1642048. Epub 2018 Sep 4. Clin Colon Rectal Surg. 2018. PMID: 30186053 Free PMC article. Review.

6

Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.

Best S, Hashiguchi T, Kittai A, Bruss N, Paiva C, Okada C, Liu T, Berger A, Danilov AV. Best S, et al. Blood Adv. 2019 Jan 8;3(1):51-62. doi: 10.1182/bloodadvances.2018026880. Blood Adv. 2019. PMID: 30617217 Free PMC article.

7

Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.

Spurgeon SE, Pindyck T, Okada C, Chen Y, Chen Z, Mater E, Abbi K, Epner EM. Spurgeon SE, et al. Leuk Lymphoma. 2011 Aug;52(8):1488-94. doi: 10.3109/10428194.2011.575489. Epub 2011 May 31. Leuk Lymphoma. 2011. PMID: 21623691

8

Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.

Lucero OM, Lee JA, Bowman J, Johnson K, Sapparapu G, Thomas JK, Fan G, Chang BH, Thiel-Klare K, Eide CA, Okada C, Palazzolo M, Lind E, Kosaka Y, Druker BJ, Lydon N, Bowers PM. Lucero OM, et al. Clin Cancer Res. 2023 Oct 13;29(20):4230-4241. doi: 10.1158/1078-0432.CCR-22-0906. Clin Cancer Res. 2023. PMID: 37199721 Free PMC article.

9

Targeting CD47 in Sézary syndrome with SIRPαFc.

Johnson LDS, Banerjee S, Kruglov O, Viller NN, Horwitz SM, Lesokhin A, Zain J, Querfeld C, Chen R, Okada C, Sawas A, O'Connor OA, Sievers EL, Shou Y, Uger RA, Wong M, Akilov OE. Johnson LDS, et al. Blood Adv. 2019 Apr 9;3(7):1145-1153. doi: 10.1182/bloodadvances.2018030577. Blood Adv. 2019. PMID: 30962222 Free PMC article. Clinical Trial.

10

Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma.

Hashiguchi T, Bruss N, Best S, Lam V, Danilova O, Paiva CJ, Wolf J, Gilbert EW, Okada CY, Kaur P, Drew L, Cidado J, Hurlin P, Danilov AV. Hashiguchi T, et al. Among authors: okada cy. Mol Cancer Ther. 2019 Sep;18(9):1520-1532. doi: 10.1158/1535-7163.MCT-18-1023. Epub 2019 Jun 26. Mol Cancer Ther. 2019. PMID: 31243099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page